Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synovial cell proliferation refers to the increase in the number of cells within the synovial membrane, particularly involving synovial lining cells (synoviocytes) and fibroblasts. Under normal conditions, proliferation rates are low, but in pathological states such as rheumatoid arthritis (RA), there is a marked increase. This hyperplasia leads to thickening of the synovium and contributes to pannus formation, resulting in joint destruction. The proliferation process can be influenced by inflammatory cytokines, angiogenesis, and innate immune receptor signaling.
Inhibition of angiogenesis (TNP-470)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synovial Cell Proliferation.